EE173 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises
Abstract
Authors
C. Udeze Y. Xie F.J. Ogunsile U. Mujumdar H. Yang X. Chen S. Jeyakumar N. Li J. Wang A. Lopez